Team:Wageningen UR/Secondary metabolites

From 2013.igem.org

(Difference between revisions)
(→Extensive applications)
 
(11 intermediate revisions not shown)
Line 21: Line 21:
document.getElementById('li_'+tab).setAttribute("class", "active");
document.getElementById('li_'+tab).setAttribute("class", "active");
}
}
 +
 +
$(window).scroll(function(){
 +
 +
    var windowPos = $(window).scrollTop(); // get the offset of the window from the top of page
 +
    var windowHeight = $(window).height(); // get the height of the window
 +
    var docHeight = $(document).height();
 +
    var docAction = (docHeight -60) - windowHeight;
 +
 +
    if( windowPos >= docAction ){
 +
        $('.tournavleft, .tournavright').addClass('mar');
 +
    } else {
 +
        $('.tournavleft, .tournavright').removeClass('mar');
 +
    }
 +
 +
});
</script>
</script>
<div class="projectheader">
<div class="projectheader">
-
<img src="https://static.igem.org/mediawiki/2013/1/13/Aspergillusheader.png">
+
<img src="https://static.igem.org/mediawiki/2013/0/02/Secmetheader.jpg">
<div class="content secmet">
<div class="content secmet">
<h1>Secondary metabolites</h1>
<h1>Secondary metabolites</h1>
Line 47: Line 62:
<div class="tournav">
<div class="tournav">
     <ul>
     <ul>
-
         <li class="first fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Why_Aspergillus_nigem">Why <i>Aspergillus nigem</i>?</a></li>
+
         <li class="firstbgsm fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Why_Aspergillus_nigem">Why <i>Aspergillus nigem</i>?</a></li>
         <li class="smbgsm current">Secondary metabolites</li>
         <li class="smbgsm current">Secondary metabolites</li>
-
         <li>Lovastatin</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Lovastatin">Lovastatin</a></li>
-
         <li>ATP Biosensor</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Modeling">Modeling</a></li>
-
         <li>pH Biosensor</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Biosensors">Biosensors</a></li>
-
         <li>Cytoskeleton and Septa</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Infrastructure">Infrastructure</a></li>
-
         <li>Chromoproteins</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Chromoproteins">Chromoproteins</a></li>
-
         <li>Host engineering</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Host_engineering">Host engineering</a></li>
-
         <li class="last">Summary</li>
+
         <li class="last"><a href="https://2013.igem.org/Team:Wageningen_UR/Summary">Summary</a></li>
     </ul>
     </ul>
</div>
</div>
Line 62: Line 77:
<div class="tournav">
<div class="tournav">
     <ul>
     <ul>
-
         <li class="first fill">Why <i>Aspergillus nigem</i>?</li>
+
         <li class="first fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Why_Aspergillus_nigem">Why <i>Aspergillus nigem</i>?</a></li>
         <li class="smbg current">Secondary metabolites</li>
         <li class="smbg current">Secondary metabolites</li>
         <li class="bgbg"><a href="https://2013.igem.org/Team:Wageningen_UR/Lovastatin">Lovastatin</a></li>
         <li class="bgbg"><a href="https://2013.igem.org/Team:Wageningen_UR/Lovastatin">Lovastatin</a></li>
-
         <li class="bgsm"><a href="https://2013.igem.org/Team:Wageningen_UR/ATP_biosensor">ATP Biosensor</a></li>
+
         <li class="bgsm"><a href="https://2013.igem.org/Team:Wageningen_UR/Modeling">Modeling</a></li>
-
         <li>pH Biosensor</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Biosensors">Biosensors</a></li>
-
         <li>Cytoskeleton and Septa</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Infrastructure">Infrastructure</a></li>
-
         <li>Chromoproteins</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Chromoproteins">Chromoproteins</a></li>
-
         <li>Host engineering</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Host_engineering">Host engineering</a></li>
-
         <li class="last">Summary</li>
+
         <li class="last"><a href="https://2013.igem.org/Team:Wageningen_UR/Summary">Summary</a></li>
     </ul>
     </ul>
</div>
</div>
Line 77: Line 92:
<div class="tournav">
<div class="tournav">
     <ul>
     <ul>
-
         <li class="first fill">Why <i>Aspergillus nigem</i>?</li>
+
         <li class="first fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Why_Aspergillus_nigem">Why <i>Aspergillus nigem</i>?</a></li>
         <li class="smbgsm current">Secondary metabolites</li>
         <li class="smbgsm current">Secondary metabolites</li>
-
         <li>Lovastatin</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Lovastatin">Lovastatin</a></li>
-
         <li>ATP Biosensor</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Modeling">Modeling</a></li>
-
         <li class="smbg"><a href="https://2013.igem.org/Team:Wageningen_UR/pH_biosensor">pH Biosensor</a></li>
+
         <li class="smbg"><a href="https://2013.igem.org/Team:Wageningen_UR/Biosensors">Biosensors</a></li>
-
         <li class="bgbg"><a href="https://2013.igem.org/Team:Wageningen_UR/Cytoskeleton_and_septa">Cytoskeleton and Septa</a></li>
+
         <li class="bgbg"><a href="https://2013.igem.org/Team:Wageningen_UR/Infrastructure">Infrastructure</a></li>
         <li class="bgsm"><a href="https://2013.igem.org/Team:Wageningen_UR/Chromoproteins">Chromoproteins</a></li>
         <li class="bgsm"><a href="https://2013.igem.org/Team:Wageningen_UR/Chromoproteins">Chromoproteins</a></li>
-
         <li>Host engineering</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Host_engineering">Host engineering</a></li>
-
         <li class="last">Summary</li>
+
         <li class="last"><a href="https://2013.igem.org/Team:Wageningen_UR/Summary">Summary</a></li>
     </ul>
     </ul>
</div>
</div>
Line 92: Line 107:
<div class="tournav">
<div class="tournav">
     <ul>
     <ul>
-
         <li class="first fill">Why <i>Aspergillus nigem</i>?</li>
+
         <li class="first fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Why_Aspergillus_nigem">Why <i>Aspergillus nigem</i>?</a></li>
         <li class="smbgsm current">Secondary metabolites</li>
         <li class="smbgsm current">Secondary metabolites</li>
-
         <li>Lovastatin</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Lovastatin">Lovastatin</a></li>
-
         <li>ATP Biosensor</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Modeling">Modeling</a></li>
-
         <li>pH Biosensor</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Biosensors">Biosensors</a></li>
-
         <li>Cytoskeleton and Septa</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Infrastructure">Infrastructure</a></li>
-
         <li>Chromoproteins</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Chromoproteins">Chromoproteins</a></li>
-
         <li class="smbgsm"><a href="https://2013.igem.org/Team:Wageningen_UR/Engineering_morphology">Host engineering</a></li>
+
         <li class="smbgsm"><a href="https://2013.igem.org/Team:Wageningen_UR/Host_engineering">Host engineering</a></li>
-
         <li class="last">Summary</li>
+
         <li class="last"><a href="https://2013.igem.org/Team:Wageningen_UR/Summary">Summary</a></li>
     </ul>
     </ul>
</div>
</div>
Line 107: Line 122:
<div class="tournav">
<div class="tournav">
     <ul>
     <ul>
-
         <li class="first fill">Why <i>Aspergillus nigem</i>?</li>
+
         <li class="first fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Why_Aspergillus_nigem">Why <i>Aspergillus nigem</i>?</a></li>
         <li class="smbgsm current">Secondary metabolites</li>
         <li class="smbgsm current">Secondary metabolites</li>
-
         <li>Lovastatin</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Lovastatin">Lovastatin</a></li>
-
         <li>ATP Biosensor</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Modeling">Modeling</a></li>
-
         <li>pH Biosensor</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Biosensors">Biosensors</a></li>
-
         <li>Cytoskeleton and Septa</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Infrastructure">Infrastructure</a></li>
-
         <li>Chromoproteins</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Chromoproteins">Chromoproteins</a></li>
-
         <li>Host engineering</li>
+
         <li><a href="https://2013.igem.org/Team:Wageningen_UR/Host_engineering">Host engineering</a></li>
         <li class="last bg"><a href="https://2013.igem.org/Team:Wageningen_UR/Summary">Summary</a></li>
         <li class="last bg"><a href="https://2013.igem.org/Team:Wageningen_UR/Summary">Summary</a></li>
     </ul>
     </ul>
Line 125: Line 140:
</html>
</html>
-
== Natural products ==
+
== Natural Products ==
<html>
<html>
       <p>Secondary metabolites are the products of metabolism not essential for normal growth, development or reproduction of an organism. They meet the secondary requirements of the producing organisms, empower them to survive interspecies competition, provide defensive mechanisms and facilitate reproductive processes. Well known sources of secondary metabolites are plants, bacteria, fungi and marine organisms such as sponges, tunicates, corals and snails.</p>
       <p>Secondary metabolites are the products of metabolism not essential for normal growth, development or reproduction of an organism. They meet the secondary requirements of the producing organisms, empower them to survive interspecies competition, provide defensive mechanisms and facilitate reproductive processes. Well known sources of secondary metabolites are plants, bacteria, fungi and marine organisms such as sponges, tunicates, corals and snails.</p>
</html>
</html>
-
== Well-known medical uses==
+
== Well-known Medical Uses==
<html>
<html>
     <p>Secondary metabolites are well-known as antimicrobials. Currently, many secondary metabolites have been proven to be effective as antibacterial or antifungal agents, anticancer drugs, cholesterol-lowering agents, immunosuppressants, antiparasitic agents, herbicides, diagnostics, and even tools for other researches.</p>
     <p>Secondary metabolites are well-known as antimicrobials. Currently, many secondary metabolites have been proven to be effective as antibacterial or antifungal agents, anticancer drugs, cholesterol-lowering agents, immunosuppressants, antiparasitic agents, herbicides, diagnostics, and even tools for other researches.</p>
Line 138: Line 153:
</html>
</html>
-
== Extensive applications ==
+
== Extensive Applications ==
<html>
<html>
   <h3>Exploiting the therapeutic potential of fungi</h3>
   <h3>Exploiting the therapeutic potential of fungi</h3>
Line 146: Line 161:
</div>
</div>
-
 
+
<div class="tournavleft">
 +
<a href="https://2013.igem.org/Team:Wageningen_UR/Why_Aspergillus_nigem" class="tourprev"><span class="prev">Previous</span><span class="tourr">Tour Page</span></a>
 +
</div>
 +
<div class="tournavright">
 +
<a href="https://2013.igem.org/Team:Wageningen_UR/Lovastatin" class="tournext"><span class="prev">Next</span><span class="tourr">Tour Page</span></a>
 +
</div>
</html>
</html>
<!--- Footer Template --->
<!--- Footer Template --->
{{:Team:Wageningen_UR/Templates/Page Footer}}
{{:Team:Wageningen_UR/Templates/Page Footer}}

Latest revision as of 22:11, 4 October 2013

Secondary metabolites

An infinity field

Natural Products

Secondary metabolites are the products of metabolism not essential for normal growth, development or reproduction of an organism. They meet the secondary requirements of the producing organisms, empower them to survive interspecies competition, provide defensive mechanisms and facilitate reproductive processes. Well known sources of secondary metabolites are plants, bacteria, fungi and marine organisms such as sponges, tunicates, corals and snails.

Well-known Medical Uses

Secondary metabolites are well-known as antimicrobials. Currently, many secondary metabolites have been proven to be effective as antibacterial or antifungal agents, anticancer drugs, cholesterol-lowering agents, immunosuppressants, antiparasitic agents, herbicides, diagnostics, and even tools for other researches.

Cholesterol-lowering agents

Compactin was first reported as a cholesterol-lowering drug by Endo in 1985. The fungal fermentation products lovastatin produced by Aspergillus terreus and Monascus ruber was found to be highly effective in reducing serum cholesterol in humans, especially cholesterol LDL levels. Lovastatin is a potent inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase and blocks formation of all products of the mammalian polyisoprenoid pathway, thus reducing the risk of cardiovascular disease.

Extensive Applications

Exploiting the therapeutic potential of fungi

In addition to their known roles in combating disease, secondary metabolites reveal surprising additional activities, which may be possible solutions to other treatment lacking diseases. Many antibiotics, bacterial pigments and plant terpenoids, are also found to have anti-HIV, antitumor, anti-ageing, immunosuppressant, antiprotozoal and antihelminth activities, thus exhibiting multifarious applications in the sphere of medicine.

Unraveling the novel applications of known secondary metabolites and exploiting a myriad of sources as microbes, plants and higher animals for screening new secondary metabolites are paving the way to treat “untreatable diseases”, and help reduce mortality rates. The study of those useful activities of secondary metabolites against life-threatening diseases may catalyze further efforts to apply them against other forms of human disease.

PreviousTour Page
NextTour Page

Retrieved from "http://2013.igem.org/Team:Wageningen_UR/Secondary_metabolites"